Iatrogenic hyperadrenocorticism and steatohepatitis caused by unapproved medicine

Internal Medicine

Volumn 47, Issue 13, 2008, Pages 1231-1236

  Kitahara, Akira ^a   Saga, Kumiko ^b   Koide, Shigeki ^c   Isobe, Tomoaki ^d   Oki, Yutaka ^e   Nakamura, Hirotoshi ^e  

^a Kitahara Medical Clinic   (Japan)

^b SEIREI MIKATAHARA GENERAL HOSPITAL   (Japan)

^c Department of Hepatology   (Japan)

^d Department of Gastroenterology   (Japan)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Desoximetasone; Glucocorticoid; Hyperadrenocorticism; Steatohepatitis

Indexed keywords

DESOXIMETASONE; DEXAMETHASONE; FLUORINE; GLYCOSYLATED HEMOGLOBIN; HYDROCORTISONE; LOSARTAN; TRIACYLGLYCEROL; GLUCOCORTICOID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CHEMICAL COMPOSITION; CORTICOTROPIN TEST; DIET THERAPY; ESOPHAGUS CANDIDIASIS; HEPATITIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERADRENOCORTICISM; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; KNEE PAIN; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PLASMA RENIN ACTIVITY; THIRST; WEIGHT GAIN; ADRENAL CORTEX HYPERFUNCTION; ARTHRALGIA; CHEMICALLY INDUCED DISORDER; FATTY LIVER; KNEE; MIDDLE AGED; SELF MEDICATION; TOXIC HEPATITIS;

ADRENOCORTICAL HYPERFUNCTION; ARTHRALGIA; DESOXIMETASONE; FATTY LIVER; GLUCOCORTICOIDS; HEPATITIS, TOXIC; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; SELF MEDICATION;

EID: 49649113942     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0988     Document Type: Article

References (14)

1. http://redpoll.pharmacy.ualberta.ca/drugbank/ (accessed 31 January 2008).
2. Wishart DS, Knox C, Guo AC, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 34 (Database issue): D668-D672, 2006.
3. Bromley PA, Miller FO, Malan J, Torres J, Vanderbeke O. Plasma cortisol levels in normal volunteers receiving either betamethasone valerate or desoximetasone by topical application. S Afr Med J 54: 239-241, 1978.
4. Cook IJ, Freinkel RK, Zugerman C, Levin DL, Radtke R. Iatrogenic hyperadrenocortism during topical steroid therapy: sssessment of systemic effects by metabolic criteria. J Am Acad Dermatol 6: 1054-1060, 1982.
5. Garden JM, Freinkel RK. Systemic absorption of topical steroids. Arch Dermatol 122: 1007-1010, 1986.
6. Kamate Y, Kamimura T, Yoshio T, et al. Systemic lupus erythematosus with steroid induced non-alcoholic steatohepatitis: a case report. Riumachi (Rheumatism) 43: 667-671. 2003 (in Japanese, Abstract in English).
7. Nanki T, Koike R, Miyasaka N. Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis. Am J Gastroenterol 94: 3379, 1999.
8. Dourakis SP, Sevastianos VA, Kaliopi P. Acute severe steatohepatitis related to prednisolone therapy. Am J Gastroenterol 97: 1074-1075, 2002.
9. Candelli M, Nista EC. Pignataro G, et al. Steatohepatitis during methylprednisdone therapy for ulcerative colitis exacerbation. J Intern Med 253: 391-392, 2003.
10. Day CP, James OFW. Steatohepatitis: a tale of two "hits"? Gastroenterology 114: 842-845, 1998.
11. Rockall AG, Sohaib SA, Evans D, et al. Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography. Eur J Endocrinol 149: 543-548, 2003.
12. Sakurai M, Takamura T, Ota T, et al. Liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease. J Gastroenterol 42: 312-317, 2007.
13. Baskol G, Baskol M, Kocer D. Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis. Clin Biochem 40: 776-780, 2007.
14. Iuchi T, Akaike M, Mitsui T, et al. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits cascular endothelial dysfunction. Circ Res 92: 81-87, 2003.